Biogen’s ALS drug gets European Commission’s marketing nod
The European Commission has granted marketing approval for Biogen Inc.’s therapy for the treatment of a form of amyotrophic lateral sclerosis.
The European Commission has granted marketing approval for Biogen Inc.’s therapy for the treatment of a form of amyotrophic lateral sclerosis.
A dairy farm worker in Michigan, US, has been infected with highly pathogenic avian influenza from sick cows —the third such case in America
Johnson & Johnson has agreed to buy the rights for an investigational skin disorder treatment from Numab Therapeutics for $1.25 billion.
The US drug regulator has approved Amen’s biosimilar, Bkemv, to treat rare blood disorders, according to a statement from the Food and Drug
About 70% of the 4.2 million deaths in 2019 attributed to air pollution were caused by cardiovascular conditions — ischaemic heart disease and
Pfizer Inc., announced a $1.5 billion “multi-year” savings plan to cut costs of goods sold, on top of a similar $4 billion initiative
HQ Team May 23, 2024: The US Centers for Disease Control and Prevention (CDC) has warned that Muslim pilgrims traveling for the annual
Research finds a sharp increase in use of weightloss drugs such as Ozempic and Wegovy among teens and young adults